65,437 trials
HIV-1
Primary: Number of Participants Reporting Local Reactogenicity Signs and Symptoms for 3 Days After VRC01LS or VRC07-523LS Administration — 7; 6; 0; 3 Participants
Actinic Keratoses · Precancerous Skin Lesion
Primary: Resolution of AK Lesions Following Microwave Treatment — 73; 2; 73; 7 AK lesions
Firearm Safety
Primary: Change in Likert Scale of Frequency of Asking About Guns in the Home When Their Child Goes to Another Person's Home, Pre-intervention and 1 Month Post-intervention…
Solid Tumor · Glioma · Angioimmunoblastic T-cell Lymphoma
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) — 3; 4; 6; 7 Participants
Dengue Fever · Dengue Hemorrhagic Fever
Primary: STAGE-I: Geometric Mean Titers (GMTs) Against Each Dengue Virus Serotype 28 Days After Last CYD Dengue Vaccination in Participants Who Were Seropositive at Baseline…
Burns
Primary: Number of Participants With Confirmed Treatment Area Closure of RECELL-treated Wounds Compared to Control (Non-inferiority) — 24; 22; 2; 4 Participants
Acne Vulgaris
Primary: Number of Participants With 0 to 4 Investigator's Global Assessment Score at Week 6 — 0; 0; 3; 3 Participants
Correction of the Moderate to Severe Nasolabial Folds
Primary: Percentage of NLFs With Treatment Success at Month 6 — 66.0; 72.8 Percentage of successfully treated NFLs
Surgery
Primary: Blood Pressure — 105; 122; 117.88 mmHg
Mild Cognitive Impairment · Ischemic Stroke
Primary: Percentage of Patients With Improved Cognitive Function (The Montreal Cognitive Assessment Test Total Score of the Baseline +1 or More) — 124; 115 Participants — p=0.02
Youth · Homelessness
Primary: Housing — 25; 28 Participants — p=0.354
Pulmonary Arterial Hypertension
Primary: Change From Baseline to Week 24 in Actigraphy Assessed Daily Life Physical Activity (DLPA) for Variables Expressed in Minutes — -15.2; -25.2; 0.2; -1.9 minutes
Hemodialysis Access · Thrombosis
Primary: Hemodialysis Access Thrombosis Rate — 0.122; 0.227 thrombotic events per patient
Adult Liver Carcinoma · Malignant Pancreatic Neoplasm · Prostate Carcinoma
Primary: Percentage of Ultrasound Images Which Are Clinically Adequate for Treatment Set-up — 100 Percent of images
PCOS
Primary: Oral Glucose Tolerance Test — 0.9 mg/dL